Metabolic Engineering of Escherichia coli for de Novo Production of Betaxanthins.
Yanan HouXue LiuShilin LiXue ZhangSili YuGuang-Rong ZhaoPublished in: Journal of agricultural and food chemistry (2020)
Betalains are emerging natural pigments with high tinctorial strength and stability, physiological activities, and fluorescent properties for potential application in food, cosmetic, and pharmaceutical industries. Betalains including yellow betaxanthins and red betacyanins are mainly restricted in the Caryophyllales plants. To expand the availability of individual betaxanthins, here, we constructed an Escherichia coli BTA6 for de novo biosynthesis of betalamic acid. Using this strain as a monoculture platform, 14 yellow and 2 red betaxanthins were produced by feeding amino acids and amines. Furthermore, we constructed an l-histidine overproducing strain using chromosome engineering to deattenuate regulation and established a coculture system. After optimization of the initial inoculation ratios and fermentation conditions, the compatible and robust coculture system produced 287.69 mg/L of histidine-betaxanthin. This is the first report on de novo production of betaxanthins in engineered E. coli using glucose as a carbon source. Our work highlights the feasibility of microbial cell factories to produce individual betalains.
Keyphrases
- escherichia coli
- wastewater treatment
- amino acid
- klebsiella pneumoniae
- single cell
- biofilm formation
- cell therapy
- microbial community
- human health
- quantum dots
- stem cells
- high throughput
- type diabetes
- blood glucose
- metabolic syndrome
- dna methylation
- staphylococcus aureus
- living cells
- skeletal muscle
- insulin resistance
- multidrug resistant
- copy number
- blood pressure
- gene expression
- pseudomonas aeruginosa
- climate change
- single molecule